Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: ME-143
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

852536-39-1

852536-39-1 structure
852536-39-1 structure
  • Name: ME-143
  • Chemical Name: 3,4-Bis(4-hydroxyphenyl)-7-chromanol
  • CAS Number: 852536-39-1
  • Molecular Formula: C21H18O4
  • Molecular Weight: 334.36500
  • Catalog: Research Areas Cancer
  • Create Date: 2016-07-22 08:08:57
  • Modify Date: 2024-01-10 14:21:04
  • ME-143 is a second-generation tumor-specific inhibitor of NADH oxidase. ME-143 inhibits the WNT/β-catenin pathway in colorectal cancer cells. ME-143 has broadly active against cancers in vitro and in vivo[1].

Name 3,4-Bis(4-hydroxyphenyl)-7-chromanol
Synonyms 3-(4-hydroxy-phenyl)-2-phenyl-thiazolidin-4-one
3-(4-hydroxyphenyl)-4-(4-hydroxyphenyl)chroman-7-ol
4-Thiazolidinone,3-(4-hydroxyphenyl)-2-phenyl
Description ME-143 is a second-generation tumor-specific inhibitor of NADH oxidase. ME-143 inhibits the WNT/β-catenin pathway in colorectal cancer cells. ME-143 has broadly active against cancers in vitro and in vivo[1].
Related Catalog
Target

NADH oxidase[1]

In Vitro ME-143 (0-100 μM; 48 hours) reduces proliferation of DLD1 cell line by approximately 40% at a concentration of 3.125 μM, and is more potent than Genistein[1]. Cell Proliferation Assay[1] Cell Line: RKO cell; DLD1 cell Concentration: 0-100 μM Incubation Time: 48 hours Result: Reduced proliferation of DLD1 cell line by approximately 40% at a concentration of 3.125 μM, and was more potent than Genistein.
In Vivo NADH氧化酶抑制剂
References

[1]. Pintova S, et al. ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells. Anticancer Res. 2017;37(4):1647-1653.

Molecular Formula C21H18O4
Molecular Weight 334.36500
Exact Mass 334.12100
PSA 69.92000
LogP 4.11150

~%

852536-39-1 structure

852536-39-1

Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ; Location in patent: Page/Page column 36; 37 ;

~%

852536-39-1 structure

852536-39-1

Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ;

~%

852536-39-1 structure

852536-39-1

Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ;

~%

852536-39-1 structure

852536-39-1

Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ;

~%

852536-39-1 structure

852536-39-1

Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ;

~%

852536-39-1 structure

852536-39-1

Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ;